04:44 PM EDT, 08/12/2025 (MT Newswires) -- ClearPoint Neuro ( CLPT ) reported a Q2 loss late Tuesday of $0.21 per diluted share, widening from a loss of $0.16 a year earlier.

One analyst surveyed by FactSet expected a loss of $0.20.

Revenue for the quarter ended June 30 was $9.2 million, up from $7.9 million a year earlier.

Two analysts polled by FactSet expected $9.2 million.

Shares were up 4.3% during after-hours trading.